POPULATION PHARMACOKINETIC AND EXPOSURE-RESPONSE ANALYSES OF A PHASE 1 STUDY OF SUTIMLIMAB IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA.

被引：0
|
作者：
Chow, T. [1 ]
Daak, A. [1 ]
Lu, Q. [2 ]
Wong, N. [1 ]
机构：
[1] Sanofi, Waltham, MA USA
[2] Sanofi, Bridgewater, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P-038
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [31] Platelet Response to Avatrombopag in Patients with Chronic Immune Thrombocytopenia: Additional Analyses from a Phase 3 Study and Its Extension
    Nagalla, Srikanth
    Vredenburg, Michael
    Tian, Wei
    Allen, Lee F.
    BLOOD, 2019, 134
  • [32] Population pharmacokinetic and exposure-response analyses for efficacy and safety of risankizumab in subjects with active Crohn's disease
    Suleiman, A.
    Goebel, A.
    Bhatnagar, S.
    D'Cunha, R.
    Liu, W.
    Pang, Y.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I514 - I516
  • [33] Population pharmacokinetic model development and exposure-response analysis of vincristine in patients with malignant lymphoma
    Igarashi, Toshiaki
    Kishi, Shinji
    Hosono, Naoko
    Higashi, Takashi
    Iwao, Takahiro
    Yano, Ryoichi
    Tsukamoto, Hitoshi
    Goto, Nobuyuki
    Yamauchi, Takahiro
    Ueda, Takanori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (04) : 501 - 511
  • [34] Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses
    Tamai, Toshiyuki
    Hayato, Seiichi
    Hojo, Seiichiro
    Suzuki, Takuya
    Okusaka, Takuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09): : 1138 - 1147
  • [35] Population pharmacokinetic and exposure-response analyses of d-amphetamine after administration of lisdexamfetamine dimesylate in Japanese pediatric ADHD patients
    Tsuda, Yoshiyuki
    Matsuo, Yumiko
    Matsumoto, Sayaka
    Wajima, Toshihiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (06) : 548 - 554
  • [36] Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma
    Xu, Hongmei
    Li, Hanbin
    Wada, Russ
    Bader, Justin C.
    Tang, Shijie
    Shah, Jatin
    Shacham, Sharon
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (01) : 69 - 79
  • [37] UPADACITINIB PHARMACOKINETIC AND EXPOSURE-RESPONSE RELATIONSHIPS IN SUBJECTS WITH CROHN'S DISEASE - ANALYSES OF PHASE 3 STUDIES
    Bhatnagar, Sumit
    Schlacter, Louisa
    Eckert, Doerthe
    Stodtmann, Sven
    Liu, Wei
    Lacerda, Ana P.
    Mohamed, Mohamed-Eslam F.
    GASTROENTEROLOGY, 2023, 164 (06) : S1100 - S1101
  • [38] POPULATION PHARMACOKINETICS (PK) OF LEBRIKIZUMAB AND EXPOSURE-RESPONSE (ER) ANALYSES OF PHASE III STUDIES IN SEVERE ASTHMA PATIENTS
    Zhu, R.
    Dirks, N. L.
    Vadhavkar, S.
    Jin, J. Y.
    Holweg, C.
    Olsson, J.
    Matthews, J.
    Putnam, W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S95 - S95
  • [39] Population Pharmacokinetic and Exposure-Response Analyses for Daratumumab in Combination Therapies for Patients with Multiple Myeloma Who Have Received 1 or More Prior Lines of Therapy
    Xu, X. Steven
    Liao, Sam
    Dimopoulos, Meletios A.
    Sonneveld, Pieter
    Ho, P. Joy
    Belch, Andrew
    Leiba, Merav
    Capra, Marcelo
    Gomez, David
    Medvedova, Eva
    Iida, Shinsuke
    Min, Chang-Ki
    Qi, Ming
    Schecter, Jordan
    Khokhar, Nushmia Z.
    Yan, Xiaoyu
    Zhang, Liping
    Clemens, Pamela L.
    BLOOD, 2016, 128 (22)
  • [40] Population PK and Exposure-Response Analyses of Icatibant in Pediatric Patients for the Treatment of Hereditary Angioedema
    Marier, J. F.
    Jomphe, Claudia
    Schranz, Jennifer
    Martin, Patrick
    Wang, Yi
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S59 - S60
12345